Top Stories
Credence MedSystems Announces a Significant Milestone Towards Scaling Manufacturing Capabilities
Credence's drug delivery devices address industry challenges in injectable drug delivery, while maintaining use of off-the-shelf syringe barrels and other primary package components in order to facilitate implementation for its pharma customers.
Credence MedSystems Secures $39.9 Million Financing to Enable Scaling of Innovative Drug Delivery and Connected Health Systems
The investment will be directed towards scaling of production capacity for the Credence Companion® and Dual Chamber Reconstitution Systems as well as development of other members of the Company’s platform of innovative drug delivery systems, including its connected health portfolio.
Greg Knight and Chester Aldridge partner to lead breakthrough clean energy electric heating system to commercialization
Senior Executives Greg Knight and Chester Aldridge have begun a long term executive level advisory engagement to actively guide leadership of Brillouin Energy Corp.’s next stage of development.
DataShapes Welcomes Chester Aldridge as Chief Evangelist for its "Human-in-the-AI-Loop" SaaS Solutions and Vector Learning™ Technology
Aldridge Tapped to Promote DataShapes' Patented Technology That Transforms Data at the Edge and Brings Insight to the Enterprise.
Aelan Cell Technologies to Showcase Advances in Next Generation Regenerative Product at 14th Annual Meeting of International Federation for Adipose Therapeutics and Science (IFATS)
Aelan's novel technology is a combination device for the controlled, versatile and measured production of biologics which has been positioned as a new generation of regenerative therapy products for multiple indications.
Aelan Cell Technologies and the Buck Institute Announce Licensing Agreement
The agreement gives Aelan world-wide rights to intellectual property. Aelan Cell Technologies today announced a licensing agreement with the Buck Institute for Research on Aging (Novato). The agreement gives Aelan world-wide rights to intellectual property describing a novel epigenetic biomarker with a granted United States patent.
News
Aelan Cell Technologies Announces Development of Novel Alzheimer's Biomarker
An early human clinical feasibility study has indicated that serological tests using the biomarker alongside other proprietary components developed by Aelan's researchers could potentially help physicians diagnose Alzheimer's disease (AD).
Aelan Cell Technologies Publishes New Research in Proceedings Of The National Academy Of Sciences
A recent study published in Proceedings of the National Academy of Sciences and conducted by a team of researchers at the Georgia Institute of Technology and Aelan Cell Technologies has identified regulatory elements that allow for the creation of a diverse range of different cell types from different genetic information.
Credence MedSystems Receives a Strategic Investment From One of the World’s Leading Pharmaceutical Companies
Novartis has invested in Credence, confirming its interest in employing Credence technology for its injectable medicines.
Gates Foundation backs Credence MedSystem’s drug-delivery device
The development project is meant to advance the safety of the Companion device for drug and vaccine products, which include storing drugs in dried form until time of use, Credence said in a news release.
US Equity Holdings CEO Named Strategic Advisor to Fraunhofer's Pompeii Sustainable Preservation Project
Chester Aldridge, Chairman and CEO of US Equity Holdings, has joined Fraunhofer's Pompeii Sustainable Preservation Project (PSPP) as a Strategic Advisor.
Ventures
Aelan Cell Technologies
Aelan Cell Technologies is engaged in the research, discovery, development and commercialization of innovative biomedical technologies for the advancement of human health and longevity.
Mount Tam Biotechnologies
Mount Tam Biotechnologies is a specialty biopharmaceutical company focused on the discovery and development of novel mTOR modulators to address serious unmet need across a range of therapeutic areas.
PV Tech Group
PV Tech Group provides a comprehensive range of services to photovoltaic manufacturers, including full-scale integration of photovoltaic manufacturing facilities (wafers, cells, modules), strategic planning, technical evaluation, process optimization and project management.
Holdings
Credence MedSystems
Credence MedSystems is a drug delivery and specialty pharmaceutical company focused on delivering medications safely for the benefit of our patients, caregivers and partners.
CURE Pharmaceutical
CURE is a preeminent developer and manufacturer of the most advanced oral thin film (CureFilm™) on the market today with an industry leading full service cGMP manufacturing facility.
Prosetta Biosciences
Prosetta Biosciences, Inc. is biotechnology company focused on developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS).
